Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
University of California Santa Barbara
Headquarters: Santa Barbara, CA, United States of America
Website: http://www.ucsb.edu
Year Founded: 1891
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Dec 23, 2023
Discovery & Translation
Inhaled COVID-19 vaccine; KRAS and GPCR maps and more
BioCentury’s roundup of translational innovations
BioCentury | Mar 3, 2023
Discovery & Translation
Sanofi’s macrolide antibiotic for TB; organoid-based target discovery for steatosis and more
BioCentury’s roundup of translational news
BioCentury | May 20, 2022
Emerging Company Profile
Inceptor: building persistence of cancer cell therapies
Inceptor aims to address cell therapy’s challenges with $37M in series A funding, a trio of platforms and a new manufacturing facility
BioCentury | Jan 1, 2021
Targets & Mechanisms
A snapshot of target innovation in 2020
An analysis of BioCentury’s Distillery captures trends from preclinical publications in 2020
BioCentury | May 1, 2020
Distillery Therapeutics
A low-density lipoprotein receptor identified as tauopathy target
BioCentury | Sep 29, 2014
Finance
Avalon-GSK bet on familiarity, speed
How Avalon, GSK chose next newcos for their pre-POC collaboration
Items per page:
1 - 10 of 39